Understand the rationale, selection and mechanism of action of antiseizure medication, past and present. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40

"Supported by an Educational Grant from Haleon" This lecture will review the incidence and prevalence of migraine headache disorders, with an emphasis on the significant impact this neurological condition has on affected individuals. We will examine both abortive and preventive pharmacological therapies, presented within the framework of first-, second-, and third-line treatment recommendations. Additionally, evidence-based information regarding the use of nutraceuticals as potential treatment options for migraine disorders will be discussed. | 1.0 CE/CME category 1 credits (1.0 Pharmacology) | Free

This lecture will focus on the assessment and identification of common tremor disorders encountered in primary care settings. We will review the clinical features that help differentiate among various types of tremors, along with key elements of the patient history and physical examination. Relevant diagnostic tests used in the evaluation of tremor disorders will also be discussed. Finally, we will explore pharmacological management strategies as part of a comprehensive approach to the treatment of common tremor conditions. | 1.5 CE/CME category 1 credits (1.0 Pharmacology) | $40

This session will provide a comprehensive overview of dietary supplements, beginning with vitamins and extending to essential minerals. Participants will explore which nutrients are truly necessary, evidence-based recommendations for supplementation, and practical guidance on how to use supplements to support a healthy lifestyle. The discussion will also address common misconceptions, potential interactions, and strategies for integrating supplements safely into everyday care. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40

In response to the public health crisis of opioid abuse and overdose, the US Food & Drug Administration issued a Risk Evaluation and Mitigation Strategy (REMS). The REMS is part of a larger federal effort to reduce risks associated with the prescribing of long-term opioid therapy. With this national response, has come a recognition that improved knowledge of opioid safety is an essential clinical practice competency for all prescribers of opioids. This program discusses pain from a contextual perspective, patient selection and assessment of risk associated with opioid use for long-term management of chronic pain, as well as the use of opioids in the acute care setting and transition of care from the acute care setting into the community. The current 2022 CDC guidelines will be discussed. Case studies will be presented to build skills of improved recognition of opioid use disorder and decision making as to when patients should be weaned off of chronic opioids. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40

You have heard about cannabis, you know a little bit of the differences between THC and CBD, and you have a vague grasp on the endocannabinoid system, now your patient wants to try medicinal cannabis. What are the BASICS that you need to know? Is this you, “I am a busy clinician, and I have 15, maybe 20 minutes to learn all that I need to know about cannabis.”? This updated lecture will provide the busy clinician with the basics they need to knowledgably discuss medical cannabis and provide patients with the essentials to move forward safely. | 1.5 CE/CME category 1 credits (1.50 Pharmacology) | $40